感染症
- SARS-CoV-2 ワクチン mRNA-1273 の有効性と安全性Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- Covid-19 外来患者に対する中和抗体カクテル REGN-COV2REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- Covid-19 外来患者に対する SARS-CoV-2 中和抗体 LY-CoV555SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
- Covid-19 肺炎による入院患者に対するトシリズマブTocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- mRNA Covid-19 ワクチン BNT162b2 の安全性と有効性Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- 隔離期間中の海兵隊員における SARS-CoV-2 の伝播SARS-CoV-2 Transmission among Marine Recruits during Quarantine
- より高齢の成人における SARS-CoV-2 mRNA-1273 ワクチンの安全性と免疫原性Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- 航空母艦における Covid-19 の集団発生An Outbreak of Covid-19 on an Aircraft Carrier
- RNA ベースの Covid-19 ワクチン候補 2 つの安全性と免疫原性Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- Covid-19 入院患者に対するトシリズマブの有効性Efficacy of Tocilizumab in Patients Hospitalized with Covid-19